Uzedy

Active Ingredient(s): Risperidone
FDA Approved: * April 28, 2023
Pharm Company: * TEVA
Category: Antipsychotic

Risperidone, sold under the brand name Risperdal among others, is an atypical antipsychotic[2] used to treat schizophrenia and bipolar disorder.[2] It is taken either by mouth or by injection (subcutaneous or intramuscular).[2] The injectable versions are long-acting and last for 2-4 weeks.[6] Common side effects include movement problems, sleepiness, dizziness, trouble seeing, constipation, and increased weight.[2 ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Uzedy 50 mg/.14ml Subcutaneous Injection, Suspension, Extended Release
NDC: 51759-305
Labeler:
Teva Pharmaceuticals USA, Inc.
Uzedy 75 mg/.21ml Subcutaneous Injection, Suspension, Extended Release
NDC: 51759-410
Labeler:
Teva Pharmaceuticals USA, Inc.
Uzedy 100 mg/.28ml Subcutaneous Injection, Suspension, Extended Release
NDC: 51759-520
Labeler:
Teva Pharmaceuticals USA, Inc.
Uzedy 125 mg/.35ml Subcutaneous Injection, Suspension, Extended Release
NDC: 51759-630
Labeler:
Teva Pharmaceuticals USA, Inc.
Uzedy 150 mg/.42ml Subcutaneous Injection, Suspension, Extended Release
NDC: 51759-740
Labeler:
Teva Pharmaceuticals USA, Inc.
Uzedy 200 mg/.56ml Subcutaneous Injection, Suspension, Extended Release
NDC: 51759-850
Labeler:
Teva Pharmaceuticals USA, Inc.
Uzedy 250 mg/.7ml Subcutaneous Injection, Suspension, Extended Release
NDC: 51759-960
Labeler:
Teva Pharmaceuticals USA, Inc.

Related Brands

Drugs with the same active ingredients